baber/WOPTO huggingface dataset:
Patent EP-0937958-A1 (EP)
Inventor: KRIMPENFORT GEROLD
IPC: F27B9/26
Filed: 1999-02-12
Abstract: The insulated structure of the trolleys divides the tunnel cross-section into a processing chamber and an under-trolley space. Air cooling beneath the trolleys is provided. The tunnel kiln in the under-trolley space (6), at least in the area used for cooling, is so divided that for each wheel track a wheel channel (10) with cooling air feed conduit (11) and next to it a warm air outlet channel (23,24) are provided. The cooling air conduits are connected to a cooling air main conduit (7) running crossways in the kiln body, through which atmospheric air can be blown into the under-trolley cooling system. The trolleys (4) have bases (14) with double walls through which air can flow. The base walls in the area of the wheel channels have cooling air inflow apertures (21) and in the other areas warm air outflow apertures (22).
Patent EP-1038974-A1 (EP)
Inventor: LEISER ROBERT-MATTHIAS
IPC: C12Q1/6844
Filed: 1999-03-26
Abstract: A method to build an in vitro synthesized nucleic acid molecule by using a starter oligonucleotide comprising a nucleic acid derivative, which is recognized and cleaved by a nucleic acid glycosylase, is new.  A method to build in vitro synthesized nucleic acid molecule comprises:  (1) building from a nucleic acid derivative, a starter oligonucleotide necessary for amplification;  (2) amplification and building of the starter oligonucleotide in the amplification product and after finishing amplification; and  (3) building the starter oligonucleotide sequence and its complementary sequence, where the building of the starter oligonucleotide and its complement comprises: (a) splitting the base of ≥ 1 derivative with a nucleic acid glycosylase, which recognizes ≥ 1 derivative;  (b) creating strand breaks at the site of the bases which are split;  (c) separating oligonucleotides by the split ends from the complements from the amplification product; and  (d) removal (hydrolysis) of the overhanging 3' ends of the amplification products by a nuclease, which can split the 3' overhanging ends of nucleic acid strands.  An Independent claim is also included for an oligonucleotide for use in a method as above.
Patent EP-0952180-A1 (EP)
Inventor: ABRIGO LUCIANO
IPC: C07C409/16
Filed: 1999-04-16
Abstract: Compositions for the polymer curing, comprising:
     A) one or more organic peroxides 
and   B) trans, trans-2,6-dimethyl-2,4,6-octatriene
Patent EP-1050757-A1 (EP)
IPC: A61K38/18
Filed: 1999-05-03
Abstract: The invention relates to a method for diagnosing or prognosing Alzheimer's disease in a
subject, or determining whether a subject is at increased risk of developing Alzheimer's
disease, comprising:
   determining a level of nerve growth factor and/or of a transcription product of a gene
coding for nerve growth factor in a sample from said subject;   and comparing said level to a reference value representing a known disease or health
status,   thereby diagnosing or prognosing said Alzheimer's disease in said subject, or determining
whether said subject is at increased risk of developing Alzheimer's disease.
Patent EP-0982580-A1 (EP)
Inventor: MIZOGUCHI IWAO
IPC: G01N21/21
Filed: 1999-08-13
Abstract: An ellipsometer comprises a light source (24),
a polarizer (28) for creating predetermined linearly
polarized light from light from the light source (24)
and irradiating the linearly polarized light onto a
first sample such as a measured sample, a reflect-back
prism (42) for reflecting back elliptically polarized
light from the first sample and irradiating it onto
a second sample such as a target sample, an analyzer
(30) for taking out minor axis components reflected
from the second sample, and a light detecting section
(36) for detecting the minor axis components of the
elliptically polarized light taken out by the analyzer
(30). The polarizer (28) and analizer (30) are
optically separated elements having a high optical
quenching ratio and are arranged so as to satisfy
crossed Nicols.
Patent EP-1000922-A1 (EP)
Inventor: OOST CARSTEN
IPC: C07C45/67
Filed: 1999-11-13
Abstract: Preparation of unsaturated ketones by reaction of the corresponding alpha , beta -unsaturated alcohol with an alkyl acetoacetate compound in the presence an organo-aluminum catalyst at constant temperature, with separation and continuous removal of CO2 and alcohol formed. Preparation of unsaturated ketones of formula (I) by reaction of the corresponding  alpha , beta -unsaturated alcohol of formula (II) with an alkyl acetoacetate compound of formula (III) in the presence of 0.1-5 mole% (based on (III)) of an organo-aluminum catalyst with separation and continuous distillative removal of CO2 and alcohol of formula R3OH formed during reaction, in a reactor containing a fractionation column, where: (A) (II) is added to the reaction mixture together with the organic catalyst without additional solvent and (III) is then added to this mixture; (B) the reaction temperature is kept constant between 175-220 degrees C; (C) the content of (III) is kept at a constant level between 0.1-10 wt.% during the reaction. R1, R3 = 1-4C alkyl; R2 = 4-30C aliphatic, cycloaliphatic or cycloaliphatic-aliphatic; a, b = optional additional bonds.
Patent EP-1009086-A1 (EP)
Inventor: OBARA RIKURO
IPC: F16C33/30
Filed: 1999-11-26
Abstract: The spindle motor comprises at last one ball bearing
formed by balls interposing between an inner ring and an
outer ring in which said inner ring and outer ring are
made of steel and said balls are made of ceramics and a
pair of said ball bearings being provided between the
spindle shaft and the rotor of the spindle motor.
Patent EP-1013559-A1 (EP)
Inventor: FREUDELSPERGER KARL DIPL-ING
IPC: B65B43/59
Filed: 1999-12-21
Abstract: The method involves moving open containers (A,B,C) along a conveyor path (1), along a separate drive in the immediate vicinity of the filling station (1) and individually into the filling station, positioning them beneath a fill hopper (2) in the station, removing them after filling and returning them to the conveyor path. The containers are individually fed along the pref. continuously operated container drive into the station with a height adjustment and positioned with a defined distance between the top of the container and the filler hopper irrespective of container height. An Independent claim is also included for an arrangement for filling containers.
Patent EP-1050786-A1 (EP)
Inventor: ERNO JEFFREY DAVID
IPC: G05B19/4097
Filed: 1999-05-05
Abstract: A method for designing, and optionally
making, an article of manufacture is shown. Customer
requirement parameters are defined and related
engineering parameters are chosen. A parametric
geometrical representation (i.e. a master model) of the
article is created in terms of geometric parameters
using a computer program. A design analysis
methodology is created and programmed (100) into a
computer code and stored on a computer medium (120)
such that the engineering parameters and the customer
requirement parameters are program inputs and the
geometric parameters of the master model are program
outputs. Specific values of the inputs are inputted
into the computer code. The computer code is run on a
digital computer (140) and specific values of the
geometric parameters of the master model are outputted.
Patent EP-0965979-A1 (EP)
Inventor: WRIGHT BARTON D
IPC: G10L15/06
Filed: 1999-06-15
Abstract: An action position is manipulated in computer-implemented speech
recognition by receiving data representing a spoken command. The command
includes a command identifier (e.g., insert before, insert after, resume with) and a
designation of at least one previously-spoken word. Speech recognition is
performed on the data to identify the command identifier and the designation.
Finally, an action position is established relative to the previously-spoken word
based on the command identifier. Text may be selected using a spoken selection
command that includes a command identifier and a text block identifier identifying
a block of previously-recognized text. At least one word included in the block of
text is not included in the text block identifier;
Patent EP-0974408-A1 (EP)
Inventor: PERRET JEAN
IPC: B21C49/00
Filed: 1999-05-04
Abstract: A band product accumulation unit including a mechanism for controlling the running of a band along a longitudinal direction, a fixed frame, a wrap-around carriage which is moveable on a track between a return position of minimum accumulation length and an out position of maximum accumulation length, wherein movement towards the out position increases a length while movement towards the return position decreases the length, the band being adapted to pass over at least one return member mounted on the wrap-around carriage so as to form at least an out portion and at least a return portion and defined by at least two spaced levels, a plurality of intermediate supporting members arranged along the track, each comprising at least one separating arm extending horizontally on at least one intermediate level disposed between two running levels of the band, each separating arm being fixed to a shaft which is pivotal about a vertical axis with respect to the fixed frame, a mechanism for controling the pivoting of each separating arm between an open position which allows the wrap-around carriage to move to the return position and a closed position wherein each separating arm extends transverse to and between the two running levels of the band, and a control mechanism for controlling the pivoting of each separating arm between the closed position and the open position.
Patent EP-1061422-A1 (EP)
Inventor: LIENHARD HEINZ DR H C
IPC: G05B17/02
Filed: 1999-06-11
Abstract: The method involves coupling process models and real processes using information technology. The process model is operated independently of the real process, to simulate and/or optimize processes and process modifications. A process realized in the process model can be selectively integrated into the real process, either completely or partially. The process model may provide a visual, animated representation of the modelled process. The representation may be displayed and/or exported in the form of a Java applet. An Independent claim is included for a method of operating an information technology system for modelling, simulation, optimization and/or control of discrete processes.
Patent EP-1063286-A1 (EP)
Inventor: TANGA MICHIFUMI
IPC: C12Q1/68
Filed: 1999-02-08
Abstract: A purpose of the present invention is to provide substrates utilized for a
library of DNA by immobilizing DNA and DNA-immobilized chips utilized for
reproducing DNA by a PCR amplifying reaction. In the present invention, PCR
amplifying method is operated by utilizing DNA-immobilized chips having DNA
immobilized on an excellent conductive substrate. A surface of the substrate
is chemically modified with a radical of which a terminal is a polar radical.
In the PCR method, DNA can be amplified for a short period by utilizing
DNA-immobilizing chips having DNA immobilized on the substrates.
Patent EP-1045861-A1 (EP)
Inventor: BURTON JACK
IPC: A61K47/48
Filed: 1999-01-14
Abstract: A method for intracellular delivery of drugs or other agents for diagnosis and therapy of malignancies or immune-mediated or inflammatory conditions. A targeting moiety of an antibody and the ligand-binding region of a selected cytokine receptor is used. The targeting moiety targets surface antigen on a specific cell population. The targeting moiety is administered to a subject, and then, after a specified interval, therapeutic or diagnostic agents linked to the cognate cytokine are given. The invention provides rapid, efficient internalization of the cytokine receptor antibody/antigen complexes. Targeting of a high-level cell surface antigen with such bispecific fusion molecules substantially increases the number of cytokine receptors over their low background level.
Patent EP-1045637-A1 (EP)
Inventor: BITENSKY MARK W
IPC: A61K35/18
Filed: 1999-01-06
Abstract: L'invention concerne des globules rouges modifiés qui tiennent lieu de plates-formes de déploiement pour d'importantes biomolécules. Lesdits globules rouges modifiés peuvent conférer, par exemple, une protection in vivo contre la vulnérabilité à un agent neurotoxique qui, dans d'autres circonstances, serait mortel.
Patent EP-1051246-A1 (EP)
Inventor: BAILEY STEPHEN
IPC: B01J20/06
Filed: 1999-02-03
Abstract: Shaped absorbent units suitable for use as chloride absorbents comprising a calcined intimate mixture of an alkali or alkaline earth, zinc and aluminium components having an alkali or alkaline earth mental to zinc atomic ratio in the range 0.5x to 2.5x and an alkali or alkaline earth metal to aluminium atomic ratio in the range 0.5x to 1.5x, where x is the valency of the alkali or alkaline earth metal, and containing from 5 to 20% by weight of a binder. Preferred compositions are made from sodium carbonate or bicarbonate, basic zinc carbonate or zinc oxide and alumina or hydrated alumina.
Patent EP-1059013-A1 (EP)
Inventor: DEACON DAVID A G
IPC: G02F1/313
Filed: 1999-02-01
Abstract: On fabrique un système de connexion optique redondant se présentant sous une forme spéciale, permettant la réalisation ultérieure de connexions optiques. En réponse aux informations spécifiant les sources optiques qui sont fonctionnelles, une autre structure peut être activée ou introduite dans le système de connexion qui guide l'énergie optique jusqu'à des sorties optiques seulement depuis les sources qui sont fonctionnelles. Selon un aspect de l'invention, la forme préliminaire présente des structures de guidage primaires couplant chacune des sources optiques primaires à une structure d'application respective, et une structure de guidage secondaire couplée à une source optique secondaire et se terminant cependant sans couplage à une structure d'application. Si les informations indiquent qu'une des sources optiques primaires n'est pas fonctionnelle, la structure qui transfère l'énergie optique de la structure d guidage secondaire dans la structure de guidage primaire correspondant à la source non fonctionnelle, peut être ajoutée ou activée. Selon un autre aspect de l'invention, la forme préliminaire comprend un matériau ayant N sources optiques et plus de N structures de guidage de sortie. Une zone d'espace est prévue dans le matériau, entre les sorties des sources optiques et les entrées des structures de guidage de sortie. Des structures de guidage supplémentaires sont formées ou activées ultérieurement en réponse aux informations, de sorte que l'énergie optique soit guidée jusqu'aux entrées des structures de guidage de sortie depuis seulement une des sources optiques fonctionelles.
Patent EP-1076735-A1 (EP)
Inventor: VIKIOE PENTTI
IPC: D21C5/02
Filed: 1999-03-12
Abstract: A method and apparatus treat fiber based material so as to reduce the loss of mineral fractions in the treatment of broke in paper production. Broke is a reusable raw material from a paper machine that contains mineral fractions which are desirably returned to the process as a raw material. The material containing minerals is dispersed into broke pulp, which is fractionated, and the accepts from the fractionation are returned to the paper manufacturing process providing for efficient and economical recovery of the minerals in broke. The mineral fraction provided in the rejects from the fractionation is treated separately before it is reused as filler or coating material in the production of paper or board.
Patent EP-1054949-A1 (EP)
Inventor: ACKLEY DONALD E
IPC: B01L3/00
Filed: 1999-02-11
Abstract: Methods of manufacture and devices for performing active biological operations utilize various structures to advantageously collect and provide charged biological materials to an array of microlocations. In one embodiment, a device includes focusing electrodes to aid in the direction and transport of materials from a collection electrode to an array. Preferably, one or more intermediate transportation electrodes are utilized, most preferably of monotonically decreasing size between the collection electrode and the array, so as to reduce current density mismatches. In another aspect, a flow cell is utilized over devices to provide containment of solution containing materials to be analyzed. In yet another embodiment, a concentric ring design is provided. Various flip-chip embodiments are disclosed.
Patent EP-0984902-A1 (EP)
Inventor: LACOUT J
IPC: A61K6/838
Filed: 1999-03-17
Abstract: A solid powder product with a Ca/P ratio of between 1.40 and 1.90 is prepared from tricalcium phosphate and tetracalcium phosphate. An aqueous solution containing calcium ions and phosphate ions with a Ca/P ratio higher than 0.20 and lower than 0.50 is prepared. The aqueous solution and the solid powder product and optionally water are mixed to obtain a mixture with a liquid/solid weight ratio of between 0.30 and 0.65 and a resulting paste with a Ca/P ratio of between 1.50 and 1.67.
Patent EP-1080159-A1 (EP)
Inventor: ERICKSON DWIGHT D
IPC: B24D3/14
Filed: 1999-03-16
Abstract: Alumina-based abrasive material having at least an internal layer is provided. Preferably, the abrasive material results from co-extrusion of at least two different sols. In some preferred processing, steps to provide multiple internal layers are conducted.
Patent EP-1074622-A1 (EP)
Inventor: HONJO TASUKU
IPC: C07K14/47
Filed: 1999-04-28
Abstract: A novel mouse polypeptide. Because of having an effect of inhibiting the proliferation of vascular smooth muscle cells, this polypeptid is applicable to the treatment of diseases in which abnormal smooth muscle proliferatoin participates, for example, arteriosclerosis and myeroma. Moreover, this polypeptide has hematopoietic cell regulatory activity, tissue forming/reparing activity, activin/inhibin activity, chemotactic/chemokinetic activity, blood coagulating and thrombotic activity, etc. Thus, it seems useful in preventing and/or treating various diseases.
Patent EP-1073460-A1 (EP)
Inventor: DEANGELIS PAUL
IPC: C12Q1/68
Filed: 1999-04-01
Abstract: The present invention relates to a nucleic acid segment having a coding region segment encoding enzymatically active  bacterial multocida , and to the use of this nucleic acid segment in the preparation of recombinant cells which produce chondroitin synthase and chondroitin polymer.
Patent EP-1073947-A1 (EP)
Title: System and method for improved program launch time
Inventor: WALSH JAMES EDWARD
IPC: G06F9/445
Filed: 1999-04-08
Abstract: Installing files on a hard disk drive in a manner that improves program launch time. After a build of a program is completed, the program is launched and the disk activity associated with disk-intensive operations is monitored to determine the order in which file portions are read from a disk during program or command launch. This data is used to create a load sequence list, which indicates the order in which various portions of the files are read during launch. The installation disks include the files and the load sequence list. During the installation process, the installation program reads the data from the load sequence list and writes the file portions so they are stored in the order prescribed by the load sequence list in contiguous clusters on the hard disk drive. The computer can then read launch-related data from the disk in the proper order from contiguous disk clusters, which minimizes or eliminates wasted time that would result from disk accesses if the disk heads had to move between non-contiguous clusters in order to read the launch-related data.
Patent EP-1031038-A1 (EP)
Inventor: ADELERHOF DERK J
IPC: G01B7/30
Filed: 1999-06-17
Abstract: A magnetic position detector comprising a soft magnetic target wheel, a magnetic sensor and a permanent magnet. The invention relates to magnetoresistive sensors in several geometrical configurations of the target wheel, the sensor and the magnet. All configurations result in a big change of direction of the magnetic field at the location of the sensor as a result of a rotation of the target wheel. The configurations have in common that the direction of the magnetic fiel at the location of the sensor, as generated by the permanent magnet, is predominantly in the plane of the sensor surface, both when the sensor is next to a slot and next to a tooth of the target wheel, the surface of the sensor being substantially normal to the direction of movement of the target wheel.
Patent EP-1071752-A1 (EP)
Inventor: KUFER PETER
IPC: C07K19/00
Filed: 1999-04-21
Abstract: Described are novel single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen, respectively. Further provided are polypeptides, wherein the above-described polypeptide comprises at least one further domain, preferably of pre-determined function. Furthermore, polynucleotides encoding said polypeptides as well as to vectors comprising said polynucleotides and host cells transformed therewith and their use in the production of said polypeptides are described. In addition, compositions, preferably pharmaceutical and diagnostic compositions are provided comprising any of the afore-described polypeptides, polynucleotides or vectors. Described is also the use of the afore-mentioned polypeptides, polynucleotides and vectors for the preparation of pharmaceutical compositions for immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma.Described are novel single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen, respectively. Further provided are polypeptides, wherein the above-described polypeptide comprises at least one further domain, preferably of pre-determined function. Furthermore, polynucleotides encoding said polypeptides as well as to vectors comprising said polynucleotides and host cells transformed therewith and their use in the production of said polypeptides are described. In addition, compositions, preferably pharmaceutical and diagnostic compositions are provided comprising any of the afore-described polypeptides, polynucleotides or vectors. Described is also the use of the afore-mentioned polypeptides, polynucleotides and vectors for the preparation of pharmaceutical compositions for immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma.
Patent EP-1092000-A1 (EP)
Title: Method for processing mineral fillers with a phosphate, said fillers and their uses
Inventor: FICHOU JEAN-PIERRE
IPC: C09K23/14
Filed: 1999-06-17
Abstract: The invention concerns mineral fillers used for making polyurethane foams, and in particular carbonate, hydroxide, silicate, sulphate fillers, and similar mineral fillers. The invention concerns in particular a method for processing mineral fillers with specific particle size distribution using treating agents such as organic phosphate, including a disaggregation step, an optionally a selection step, so as to improve the techniques for manufacturing polyurethane foams either by foaming without swelling auxiliary or with swelling auxiliary, such as CO2, and composite polyurethane, by reducing the time for mixing said processed filler with polyol and other reagents. The invention has numerous uses such as for making block foams or moulded foams, for mattresses and the like, in the car manufacturing industry, for making various industrial parts, etc.